RxDoctor Payments Data

Peggy Burpee, DO

Family Medicine · San Angelo, TXNPI 1366424368

Payments from drug & device makers

$569in general payments, 2019–2025

Across 36 payments — averaging $15.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$249
  • AstraZeneca$83
  • Lilly USA, LLC$60
  • AbbVie$56
  • GSK$24
  • Astellas Pharma US Inc$21
  • plus $76 from 5 others

What the payments were for

  • Food & beverage$569100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$569 in reported general payments places this provider in the 50th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$117,775
Medicare patients
337
Services billed
2,052

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide43$37,842
MounjaroTirzepatide21$28,393
JardianceEmpagliflozin28$24,617
EliquisApixaban20$23,253
JanuviaSitagliptin Phosphate24$22,771
MyrbetriqMirabegron25$18,807
TradjentaLinagliptin13$18,667
EntrestoSacubitril/Valsartan14$13,336
Breo ElliptaFluticasone/Vilanterol27$10,959
SymbicortBudesonide/Formoterol Fumarate22$6,614
Levothyroxine Sodium374$3,712
Gabapentin205$3,056
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$2,889
Atorvastatin Calcium269$2,008
Albuterol Sulfate HfaAlbuterol Sulfate69$1,937

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$13$43,28541 claims
Novo NordiskOzempic$249$37,84243 claims
Lilly USA, LLCMounjaro$60$28,39321 claims
MerckJanuvia$14$22,77124 claims
Astellas Pharma US IncMyrbetriq$21$18,80725 claims
NovartisEntresto$12$13,33614 claims
GSKBreo Ellipta$24$10,95927 claims
AstraZenecaSymbicort$83$6,61422 claims
AbbVieSynthroid, Armour Thyroid$56$2,79241 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 8,760 family medicine providers in Texas.

Other family medicine in San Angelo

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →